Cargando…
Current treatment of IgA nephropathy
IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and GFR loss, if any, is slow. The mainstay of therapy therefore is optimized supportive care, i.e., measures that lower blood p...
Autores principales: | Floege, Jürgen, Rauen, Thomas, Tang, Sydney C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551131/ https://www.ncbi.nlm.nih.gov/pubmed/34495361 http://dx.doi.org/10.1007/s00281-021-00888-3 |
Ejemplares similares
-
IgA nephropathy: a perspective for 2021
por: Floege, Jürgen, et al.
Publicado: (2021) -
Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020) -
Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study
por: Seikrit, Claudia, et al.
Publicado: (2022) -
Recent advances in the understanding and management of IgA nephropathy
por: Lai, Kar Neng, et al.
Publicado: (2016) -
IgA Nephropathy: Current Treatment and New Insights
por: Petrou, Dimitra, et al.
Publicado: (2023)